Metabolic engineering Escherichia coli for efficient production of icariside D2
Abstract Background Icariside D2 is a plant-derived natural glycoside with pharmacological activities of inhibiting angiotensin-converting enzyme and killing leukemia cancer cells. Production of icariside D2 by plant extraction and chemical synthesis is inefficient and environmentally unfriendly. Mi...
Main Authors: | Xue Liu, Lingling Li, Jincong Liu, Jianjun Qiao, Guang-Rong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Biotechnology for Biofuels |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13068-019-1601-x |
Similar Items
-
Metabolic engineering of Escherichia coli for de novo production of 3-phenylpropanol via retrobiosynthesis approach
by: Zhenning Liu, et al.
Published: (2021-06-01) -
Icariside II alleviates ischemic retinopathy by modulating microglia and promoting vessel integrity
by: Dan Yan, et al.
Published: (2023-05-01) -
Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats
by: Tao Cheng, et al.
Published: (2015-12-01) -
Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers
by: Fei Xu, et al.
Published: (2021-04-01) -
Engineering Escherichia coli to Utilize Erythritol as Sole Carbon Source
by: Fang Ba, et al.
Published: (2023-05-01)